The Patent Finder

Octane Biotech Inc.

Also on record
Records under this name other than the patents Octane Biotech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.

Showing 1 to 7 of 7 · Back to Octane Biotech Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,499,780Advanced tissue engineering system
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,546,142Reverse flow perfusion of three-dimensional scaffolds
Lapsed on the fee record
Ended Oct 1, 2025 · USPTO record
Lapsed on the fee recordEnded Oct 1, 2025USPTO record
US 8,492,140Automated tissue engineering system
Term ended
Term ended Jun 7, 2025 · USPTO record
Term endedTerm ended Jun 7, 2025USPTO record
US 9,534,195Automated tissue engineering system
Formerly held
Term ended
Term ended Aug 5, 2024 · USPTO record
Term endedTerm ended Aug 5, 2024USPTO record
US 10,723,986Automated tissue engineering system
Formerly held
Term ended
Term ended May 30, 2024 · USPTO record
Term endedTerm ended May 30, 2024USPTO record
US 9,701,932Automated tissue engineering system
Formerly held
Term ended
Ended no later than Apr 8, 2023 · USPTO record
Term endedEnded no later than Apr 8, 2023USPTO record
US 10,844,338Automated tissue engineering system
Term ended
Term ended Apr 8, 2023 · USPTO record
Term endedTerm ended Apr 8, 2023USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited